A team of scientists at UCL have found that blood tests measuring the hallmark Alzheimer’s protein, beta-amyloid (amyloid), could radically reduce the cost of clinical trials and potentially open the door to treating the disease earlier.
Dr Ashvini Keshavan is a Post-doctoral clinical research associate and Neurology Registrar at University College London, hear what inspired her to follow a career into medicine and discover a passion for dementia research.
Post-doctoral clinical research associate and Neurology Registrar at UCL and National Hospital for Neurology and Neurosurgery researching Biofluid biomarkers of Alzheimer’s disease, rediscovering Odissi.
Adam Smith
Dr Ashvini Keshavan
Dementia Researcher